Epsilon aminocaproic acid in hemophiliacs undergoing dental extractions: a concise review.
On the basis of our review of the literature, it can be concluded that the advantages of E-A.C.A. include (1) safe execution of oral surgical procedures in persons with hemophilia of varying degrees of severity, (2) decrease or total elimination of the need for specific factor replacement therapy, (3) extremely positive cost effectiveness, and (4) reproducibility of results at different hemophilia centers.
D000614:Aminocaproates / Q000627:therapeutic use*; D015119:Aminocaproic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D005169:Factor VIII / Q000627:therapeutic use; D005342:Fibrinolysis / Q000187:drug effects; D006467:Hemophilia A / Q000188:drug therapy* / Q000503:physiopathology; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D014081:Tooth Extraction
D000614:Aminocaproates; D005169:Factor VIII; D015119:Aminocaproic Acid